Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Thienger

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell|September 15, 2020
SETting Up for Epigenetic Regulation of Advanced Prostate CancerPhillip Thienger, Mark A Rubin
Nature Cell Biology|January 9, 2021
Prostate cancer hijacks the microenvironmentPhillip Thienger, Mark A Rubin
Cancer Research|February 16, 2026
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate CancerPhillip Thienger, Dilara Akhoundova, Mark A Rubin
Diagnostic Pathology|June 21, 2024
Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical courseDilara Akhoundova, Stefanie Fischer, Joanna Triscott, et al.
ACS Chemical Biology|September 26, 2019
Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer PathwayPhilipp Ottis, Chiara Palladino, Phillip Thienger, et al.
Cancer Immunology Research|November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor ImmunityLisa C Wellinger, Simon J Hogg, Dane M Newman, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader moleculesPhillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Cancer Research|January 14, 2026
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader MoleculesPhillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|September 15, 2020
SETting Up for Epigenetic Regulation of Advanced Prostate CancerPhillip Thienger, Mark A Rubin
Nature Cell Biology|January 9, 2021
Prostate cancer hijacks the microenvironmentPhillip Thienger, Mark A Rubin
Cancer Research|February 16, 2026
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate CancerPhillip Thienger, Dilara Akhoundova, Mark A Rubin
Diagnostic Pathology|June 21, 2024
Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical courseDilara Akhoundova, Stefanie Fischer, Joanna Triscott, et al.
ACS Chemical Biology|September 26, 2019
Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer PathwayPhilipp Ottis, Chiara Palladino, Phillip Thienger, et al.
Cancer Immunology Research|November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor ImmunityLisa C Wellinger, Simon J Hogg, Dane M Newman, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader moleculesPhillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Cancer Research|January 14, 2026
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader MoleculesPhillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
Pageof 1